This is a really great report and shows how strong the management team are in terms of cost control and product development. They've launched a new product line, while making a substantial profit (for their company size) of 1.3million in a single quarter.
Even if Zoleo doesn't have the immediate impact that some here expect, 1.3mil per quarter would be around 5million annualised, or a PE currently of less than 4... but we know it's cyclical, plus there is prod dev costs, so its more like a PE of 8-10, but that's still undervalued for a growth company with a solid moat in a niche but expanding industry.
This is a really great report and shows how strong the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.020(14.3%) |
Mkt cap ! $10.37M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 12.0¢ | $830 | 6.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61094 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 35000 | 1 |
View Market Depth
| Last trade - 14.30pm 25/06/2025 (20 minute delay) ? |
| BCC (ASX) Chart |